retatrutide type 2 diabetes trial results Weight loss with as compared to currently licenced obesity New GLP-3 drug significantly slashes

Possible Side Effects / Considerations Mild gastrointestinal symptoms such as nausea, bloating, or diarrhea (often most noticeable during early weeks)

Injecting in the morning means that peak drug activity, and therefore peak GI effects, occurs during the daytime when you are active and can manage symptoms more easily

market for longer as the diabetes drug Mounjaro

Common side effects of Orforglipron 3 mg include mild nausea and diarrhea, while severe side effects occur less frequently compared to other GLP-1 agonists

Quality varies significantly between suppliers

Physicians most frequently cited GI side effectsparticularly persistent nausea and vomitingas the primary reasons for discontinuation